Withings Launches StethO Sense, the AI of BeamO Starting October 1st

Key Takeaways

1StethO Sense, AI analysis of heart and lung sounds from the BeamO, will be available on October 1 for Withings+ subscribers

2The service uses eMurmur Heart AI for the heart and StethoMe for the lungs, with unlimited usage and shareable results

3A one-month free trial is offered to current holders and new buyers of the $250 BeamO

Why it matters : StethO Sense enhances Withings' connected health offering by making advanced analyses accessible at home, without diagnostic value, to share with a doctor.

Withings launches StethO Sense, an AI analysis of BeamO recordings, announced at IFA 2026 and available to Withings+ subscribers starting October 1. The service relies on eMurmur Heart AI and StethoMe, offers unlimited usage, does not provide diagnoses, and integrates into Withings' cardiology ecosystem.

Non-diagnostic results and free trial starting October 1

StethO Sense allows for unlimited use, but its results do not constitute medical diagnoses and can be exported to be shared with a healthcare professional. The service will be accessible to Withings+ subscribers starting October 1. BeamO users who purchased their device before this date will benefit from a one-month free trial of Withings+, as will those who purchase a BeamO for $250 starting October 1. The Withings+ subscription is offered at $10 per month or $100 per year.

Two distinct AI partners for heart and lung analysis

Withings utilizes eMurmur Heart AI for the analysis of heart murmurs and StethoMe for the interpretation of lung sounds. eMurmur, a company specializing in medical AI, developed eMurmur Heart AI, whose algorithm has been validated in peer-reviewed clinical studies in both children and adults, according to Withings. The tool analyzes heart recordings taken in one of four positions within seconds, distinguishing between the absence of a murmur, abnormal and innocent murmurs, and providing a confidence score. StethoMe applies an age-appropriate protocol, with six recording points for children and eight for adults, then calculates a Respiratory Index from zero to 100 based on the quality of breathing, sounds, respiratory rate, and heart rate. StethoMe is intended for general monitoring of lung sounds and is not designed for individuals with a diagnosed respiratory condition, such as asthma, COPD, or bronchitis. BeamO and StethO Sense are suitable for both children and adults.

Le brief IA que lisent les pros

Le brief IA que les pros lisent chaque soir

Les 7 actus IA du jour, décryptées en 5 min. Gratuit.

Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.

Choisissez votre rythme

Gratuit · Pas de spam · Désabonnement en 1 clic

Access via the Withings app and complement to the Cardio Check-Up

StethO Sense is integrated into the Withings app and requires a premium Withings+ subscription. The user can choose to analyze a heart or lung recording and receives results within seconds. The service has been designed to complement Withings+ Cardio Check-Up, which allows users to send an ECG recording to a cardiologist for review within 24 hours, up to four times a year. According to Livia Robic, families can record heart sounds at home in seconds, as often as they wish, to build a file to present to their doctor, without replacing a consultation.

Context: announcement at IFA 2026 and reminder about BeamO

Withings introduced StethO Sense at IFA 2026, with availability announced for October 1 for Withings+ subscribers. The service relies on third-party AI analysis of heart and lung recordings from the BeamO. The BeamO is a three-in-one device combining a stethoscope, electrocardiogram, and thermometer, FDA-approved and marketed since last November.